Abnormal elevation of IFN levels during early development is among the most important clinical phenotype observed in AGS patients, which results from mutational loss of functions in several proteins associated with nucleic acid metabolism, such as SAMHD1 (21, 24, 27). The gene discussed is SAMHD1; the disease is Aicardi-Goutieres syndrome.